Market Overview:
The global neuro-oncological diseases device market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of neuro-oncological diseases, rising demand for advanced diagnostic and treatment procedures, and growing awareness about neuro-oncological diseases. The global neuro-oncological devices market is segmented on the basis of type into MRI, CT scan, PET scan, and others. The MRI segment is expected to account for the largest share of the global neuro-oncological devices market in 2018. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to increasing demand for MRI scans for diagnosis and treatment purposes. On the basis of application, hospitals are expected to account for the largest share of the global Neuro Oncol Devices Market in 2018 followed by clinics & diagnostics centers owing rise incidences cancer patients seeking better healthcare services across globe .Reference laboratories are also anticipated witness highest growth rate over next few years owing technological advancements with introduction new products coupled rising number cancer patients opting molecular testing as part their initial diagnosis procedure .
Product Definition:
A Neuro-Oncological Diseases Device is used to diagnose and treat neuro-oncological diseases, which are tumors that form in the brain or spinal cord. This device helps to improve the accuracy of diagnosis, as well as providing a more targeted treatment plan.
MRI:
Magnetic Resonance Imaging (MRI) is a diagnostic medical device that uses magnetic fields and radio waves to produce images of body tissues. MRI works by detecting the presence of hydrogen nuclei in body tissues, which causes water molecules to vibrate and create an image. It is mainly used for diagnosing diseases such as stroke, brain tumors or infections like meningitis & spinal cord injuries.
CT Scan:
A computed tomography scan (CT) is a diagnostic medical procedure that utilizes X-rays to obtain detailed information about the targeted area. In this procedure, a computer controls the X-ray source and detector which allows multiple, rapid scans to be performed in quick succession. CT scanning is an effective method for obtaining precise images of complex body parts such as the brain, lungs, liver and kidney etc., without exposure to radiation or harmful chemicals.
Application Insights:
Based on application, the global neuro-oncological diseases device market is segmented into hospitals, clinics, diagnostics centers, reference laboratories and medical research institutes. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities and highly skilled staff. Moreover, presence of a dedicatedNeurology Department at most hospitals increases revenue generation in this sector. Clinics are expected to witness significant growth over the forecast period due to increasing awareness about early diagnosis and treatment options for various cancers including brain cancer. The majority of patients suffering from brain cancer make their visits/treatment at clinics as they can get appointments quickly there as compared to hospitals or other healthcare facilities.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, availability of advanced technologies, and high adoption rate for new devices. The U.S.-based companies are involved in extensive research activities to develop novel radiotherapy procedures and imaging modalities for brain tumor management that comply with evolving regulatory guidelines worldwide.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing healthcare expenditure levels by governments as well as individuals, rising awareness about early diagnosis & treatment methods, growing disposable income levels coupled with rapid urbanization trends across countries such as India and China which has led to an increase in construction of hospitals and diagnostic centers for neuro-oncological diseases including malignant tumors affecting brain or spinal cord among others (Kumar et al., 2016). Moreover, a rise in medical tourism due to low cost treatment options will also boost regional growth during the forecast period (Hospitals24/7; 2017).
Growth Factors:
- Increasing incidence of neuro-oncological diseases
- Growing awareness about neuro-oncological diseases and their treatment options
- Rising demand for better and more effective treatment options for neuro-oncological diseases
- Technologically advanced devices for the diagnosis and treatment of neuro-oncological diseases becoming available in the market
- increasing funding for research on neuro-oncological diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Neuro-Oncological Diseases Device Market Research Report
By Type
MRI, CT Scan, PET, Others
By Application
Hospitals, Clinics, Diagnostics Centers, Reference Laboratories, Medical Research Institutes, Others
By Companies
Siemens Healthcare, Philips Healthcare, Canon Medical Systems, GE Healthcare, Hitachi Medical, Siemens Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
163
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Neuro-Oncological Diseases Device Market Report Segments:
The global Neuro-Oncological Diseases Device market is segmented on the basis of:
Types
MRI, CT Scan, PET, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostics Centers, Reference Laboratories, Medical Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens Healthcare
- Philips Healthcare
- Canon Medical Systems
- GE Healthcare
- Hitachi Medical
- Siemens Healthcare
Highlights of The Neuro-Oncological Diseases Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- MRI
- CT Scan
- PET
- Others
- By Application:
- Hospitals
- Clinics
- Diagnostics Centers
- Reference Laboratories
- Medical Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neuro-Oncological Diseases Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A neuro-oncological diseases device is a medical device that helps diagnose and treat cancer by measuring brain tumors.
Some of the key players operating in the neuro-oncological diseases device market are Siemens Healthcare, Philips Healthcare, Canon Medical Systems, GE Healthcare, Hitachi Medical, Siemens Healthcare.
The neuro-oncological diseases device market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neuro-Oncological Diseases Device Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Neuro-Oncological Diseases Device Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Neuro-Oncological Diseases Device Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Neuro-Oncological Diseases Device Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Neuro-Oncological Diseases Device Market Size & Forecast, 2020-2028 4.5.1 Neuro-Oncological Diseases Device Market Size and Y-o-Y Growth 4.5.2 Neuro-Oncological Diseases Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 MRI
5.2.2 CT Scan
5.2.3 PET
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostics Centers
6.2.4 Reference Laboratories
6.2.5 Medical Research Institutes
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neuro-Oncological Diseases Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neuro-Oncological Diseases Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 MRI
9.6.2 CT Scan
9.6.3 PET
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostics Centers
9.10.4 Reference Laboratories
9.10.5 Medical Research Institutes
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 MRI
10.6.2 CT Scan
10.6.3 PET
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostics Centers
10.10.4 Reference Laboratories
10.10.5 Medical Research Institutes
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 MRI
11.6.2 CT Scan
11.6.3 PET
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostics Centers
11.10.4 Reference Laboratories
11.10.5 Medical Research Institutes
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 MRI
12.6.2 CT Scan
12.6.3 PET
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostics Centers
12.10.4 Reference Laboratories
12.10.5 Medical Research Institutes
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 MRI
13.6.2 CT Scan
13.6.3 PET
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostics Centers
13.10.4 Reference Laboratories
13.10.5 Medical Research Institutes
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neuro-Oncological Diseases Device Market: Competitive Dashboard
14.2 Global Neuro-Oncological Diseases Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens Healthcare
14.3.2 Philips Healthcare
14.3.3 Canon Medical Systems
14.3.4 GE Healthcare
14.3.5 Hitachi Medical
14.3.6 Siemens Healthcare